Get the Stockscreener App
10.31
0.00%
0.00
After Hours:
10.31
Voyager Acquisition Corp stock is traded at $10.31, with a volume of 25,018.
It is up +0.00% in the last 24 hours and up +0.49% over the past month.
Voyager Acquisition Corp is a blank check company.
See More
Previous Close:
$10.31
Open:
$10.31
24h Volume:
25,018
Relative Volume:
0.30
Market Cap:
$260.84M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.49%
6M Performance:
+2.89%
1Y Performance:
+0.00%
1-Day Range:
$10.31
$10.31
1-Week Range:
$10.31
$10.31
52-Week Range:
$9.97
$11.20
Voyager Acquisition Corp Stock (VACH) Company Profile
Name
Voyager Acquisition Corp
Sector
Industry
Phone
03477204333
Address
C/O WINSTON & STRAWN LLP, HOUSTON
Compare VACH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VACH
Voyager Acquisition Corp
|
10.31 | 326.05M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
7.23 | 1.89B | 2.82B | -191.60M | -407.10M | -0.6794 |
|
AACT
Ares Acquisition Corporation Ii
|
11.44 | 698.40M | 0 | 16.92M | -1.35M | 0.29 |
|
CEP
Cantor Equity Partners Inc
|
40.33 | 516.22M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.42 | 464.89M | 0 | 0 | 0 | 0.00 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.75 | 463.16M | 0 | 1.30M | 0 | 0.0301 |
Voyager Acquisition Corp Stock (VACH) Latest News
Toronto Dominion Bank Buys Shares of 425,123 Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
Two Sigma Investments LP Acquires Shares of 550,000 Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform - The Manila Times
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform - GlobeNewswire Inc.
425,123 Shares in Voyager Acquisition Corp. (NASDAQ:VACH) Purchased by Toronto Dominion Bank - MarketBeat
Brooklyn Comes Together to Celebrate Marine Park at the Garden of Giving Gala - Canarsie Courier -
TENOR CAPITAL MANAGEMENT Co. L.P. Takes Position in Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
D. E. Shaw & Co. Inc. Buys Shares of 1,089,000 Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer - GlobeNewswire
LMR Partners LLP Purchases Shares of 2,178,000 Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
Hudson Bay Capital Management LP Has $12.53 Million Holdings in Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
Tower Research Capital LLC TRC Increases Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Brokerages - Defense World
Voyager Acquisition Corp./Cayman Islands SEC 10-Q Report - TradingView
Mississippi Gaming Commission Meeting Report May 2025 - The National Law Review
ManufacturingSpecialty Pharma Archives - Investors in Healthcare
Schonfeld Strategic Advisors LLC Makes New $1 Million Investment in Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
543,446 Shares in Voyager Acquisition Corp. (NASDAQ:VACH) Acquired by Centiva Capital LP - MarketBeat
Bulldog Investors LLP Invests $3.92 Million in Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
Still a strong start for 2025, even as biopharma deals drop to $12.8B in April - BioWorld MedTech
Voyager - Ross Video
Veraxa Biotech AG’s Merger With Voyager Acquisition Corp. - Global Legal Chronicle
Aristeia Capital L.L.C. Invests $11.04 Million in Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
The Pharma Letter M&A roundupApril 2025 - The Pharma Letter
Wolverine Asset Management LLC Increases Stake in Voyager Acquisition Corp - GuruFocus
Veraxa and OmniAb to develop bispecific ADC tumour programme - MSN
Whitebox Advisors LLC Purchases Shares of 150,000 Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
Veraxa Biotech, OmniAb collaborate on bispecific ADC programme - World Pharmaceutical Frontiers
European de-SPAC M&A soars back — Dealspeak EMEA - ION Analytics
Swiss biotech firm Veraxa to list on Nasdaq in $1.64 billion SPAC deal - MSN
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program - marketscreener.com
Critical Metals Discovery Sends Junior Miner Stock Surging - The Globe and Mail
Berkley W R Corp Purchases New Shares in Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
1,518,939 Shares in Voyager Acquisition Corp. (NASDAQ:VACH) Purchased by AQR Arbitrage LLC - MarketBeat
Shaolin Capital Management LLC Buys New Position in Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
BlackRock, Inc. Reduces Stake in Voyager Therapeutics Inc - GuruFocus
First Look: True Anomaly's $260m, Marcelo Claure's move, Tether's buy - Axios
Veraxa to go public in $1.6bn SPAC deal with Voyager - MSN
Heights Capital Management Inc. Takes Position in Voyager Acquisition Corp. (NASDAQ:VACH) - MarketBeat
Duane Morris Represents Veraxa in $1.3 Billion SPAC Merger Agreement - Duane Morris LLP
Veraxa Biotech to merge with SPAC Voyager in $1.64 billion deal - MSN
Veraxa Biotech to go public via $1.64bn SPAC deal with Voyager Acquisition - World Pharmaceutical Frontiers
Switzerland: Voyager Acquisition Corp combines with Veraxa for Nasdaq IPO - Investors in Healthcare
Voyager Acquisition Corp Stock (VACH) Financials Data
There is no financial data for Voyager Acquisition Corp (VACH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.18%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):